statistiche ricercatore

PAROLARO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	15.455
EU - Europa	8.533
AS - Asia	4.908
SA - Sud America	614
AF - Africa	81
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	8
Totale	29.614

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	15.303
IT - Italia	4.192
SG - Singapore	1.720
UA - Ucraina	1.457
CN - Cina	936
SE - Svezia	772
VN - Vietnam	744
TR - Turchia	631
HK - Hong Kong	545
BR - Brasile	521
FI - Finlandia	411
DE - Germania	361
IE - Irlanda	356
GB - Regno Unito	285
FR - Francia	282
RU - Federazione Russa	191
IN - India	86
CA - Canada	79
JP - Giappone	57
MX - Messico	54
BD - Bangladesh	41
NL - Olanda	40
PL - Polonia	33
BE - Belgio	30
ZA - Sudafrica	29
AR - Argentina	28
ES - Italia	25
CZ - Repubblica Ceca	24
IQ - Iraq	23
AT - Austria	16
PK - Pakistan	16
EU - Europa	15
CO - Colombia	14
NG - Nigeria	14
MY - Malesia	11
VE - Venezuela	11
AE - Emirati Arabi Uniti	10
CL - Cile	10
MA - Marocco	10
EC - Ecuador	9
IL - Israele	9
JO - Giordania	9
LT - Lituania	9
UZ - Uzbekistan	9
NP - Nepal	8
BG - Bulgaria	7
DO - Repubblica Dominicana	7
AU - Australia	6
EG - Egitto	6
PH - Filippine	6
PY - Paraguay	6
SA - Arabia Saudita	6
UY - Uruguay	6
DK - Danimarca	5
ID - Indonesia	5
KE - Kenya	5
KR - Corea	5
PT - Portogallo	5
AL - Albania	4
BO - Bolivia	4
CH - Svizzera	4
KZ - Kazakistan	4
MD - Moldavia	4
PE - Perù	4
AZ - Azerbaigian	3
DZ - Algeria	3
HU - Ungheria	3
OM - Oman	3
PS - Palestinian Territory	3
RO - Romania	3
TN - Tunisia	3
AO - Angola	2
BH - Bahrain	2
CI - Costa d'Avorio	2
GA - Gabon	2
GE - Georgia	2
GR - Grecia	2
GT - Guatemala	2
HN - Honduras	2
IR - Iran	2
JM - Giamaica	2
LB - Libano	2
LU - Lussemburgo	2
NZ - Nuova Zelanda	2
PA - Panama	2
RS - Serbia	2
SK - Slovacchia (Repubblica Slovacca)	2
SN - Senegal	2
AM - Armenia	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
BN - Brunei Darussalam	1
BT - Bhutan	1
CR - Costa Rica	1
EE - Estonia	1
ET - Etiopia	1
GN - Guinea	1
HR - Croazia	1
KH - Cambogia	1
KW - Kuwait	1
Totale	29.602

Salva come PNG Salva come JPEG

Città	#
Milan	2.864
Fairfield	1.834
Ashburn	1.257
Woodbridge	1.128
Jacksonville	1.101
Chandler	1.089
San Jose	979
Singapore	940
Houston	839
Seattle	798
Wilmington	728
Ann Arbor	659
Cambridge	607
Hong Kong	536
Dearborn	393
Princeton	380
Dublin	355
Izmir	352
Nyköping	349
Dallas	282
The Dalles	269
Beijing	246
Rome	237
Boardman	224
Dong Ket	218
Como	192
Chicago	187
Lauterbourg	174
San Mateo	162
New York	161
Ho Chi Minh City	108
Los Angeles	90
San Diego	89
Hanoi	83
Santa Clara	69
Ogden	61
Helsinki	60
Washington	60
São Paulo	53
Tokyo	53
Hefei	51
London	50
Kunming	43
Munich	40
Orem	40
Guangzhou	39
Norwalk	38
Mexico City	37
Nanjing	35
Toronto	34
Warsaw	33
Brussels	30
Chennai	26
Council Bluffs	26
Varese	25
Brooklyn	23
Ponte Lambro	23
Brno	22
Montreal	22
Denver	19
Johannesburg	19
Nanchang	19
Phoenix	19
Verona	19
Atlanta	18
Mcallen	18
Redwood City	18
Frankfurt am Main	17
Kocaeli	17
Berlin	16
Da Nang	16
Düsseldorf	16
Jinan	16
Nuremberg	16
Ankara	15
Manchester	15
Stockholm	15
Cagliari	14
Fuzhou	14
Poplar	14
Shanghai	14
Falls Church	13
San Francisco	13
Amsterdam	12
Carbonara Al Ticino	12
Edinburgh	12
Kuala Lumpur	11
Mumbai	11
Naples	11
Shenzhen	11
Abuja	10
Boston	10
Hangzhou	10
Paris	10
Zhengzhou	10
Dhaka	9
Shenyang	9
Amman	8
Belo Horizonte	8
Chengdu	8
Totale	21.465

Salva come PNG Salva come JPEG

Nome	#
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	316
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	285
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	285
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	278
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	272
Assay of GTPγS binding in autoradiography	262
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	259
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	256
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	256
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	250
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	246
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi	245
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	237
A molecular basis of analgesic tolerance to cannabinoids	236
MeCP2 related studies benefit from the use of CD1 as genetic background	235
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	234
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	232
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	231
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	224
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	223
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	217
New vistas on cannabis use disorder	217
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	216
Long lasting consequences of cannabis exposure in adolescence.	214
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	213
Endocannabinoids and Mental Disorders.	212
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat	209
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	208
Cannabinoids and opioids share cAMP pathway in rat splenocytes	207
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche	206
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	205
Role of endocannabinoids in regulating drug dependence	203
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	203
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor.	199
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	196
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	195
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	195
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	195
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	192
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	191
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	189
Expression and function of the endocannabinoid system in glial cells.	188
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw	188
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	188
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	186
Cannabinoids and Drugs of abuse	185
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	185
The endocannabinoid system and psychiatric disorders.	184
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	184
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	183
Endocannabinoids and Drug Dependence	182
The endocannabinoid system and schizophrenia: integration of evidence.	180
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	179
Sex-dependent vulnerability to cannabis abuse in adolescence	177
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	176
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	175
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	173
Neurobiological mechanisms underlying cannabis-induced memory impairment	173
Molecular and cellular basis of cannabinoid and opioid interactions	172
Endocannabinoids in the immune system and cancer	170
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	170
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	167
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	167
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects	167
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system	165
Cannabidiol inhibits angiogenesis by multiple mechanisms	164
A role of nitric oxide in WIN 55,212-2 tolerance in mice.	164
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	162
The psychoactive ingredient of marijuana induces behavioural sensitization	161
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	161
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	160
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	160
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates.	158
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat	157
Cholera toxin effects on body temperature changes induced by morphine.	157
Alterazioni cellulari indotte da farmaci d'abuso e da stimoli avversivi non evitabili nel sistema nervoso centrale di ratto	156
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	155
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	155
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze	155
Presence and functional regulation of cannabinoid receptors in immune cells	154
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors	154
Cannabinoids as potential new therapy for the treatment of gliomas.	153
Alterazioni cellulari e molecolari presenti nel sistema nervoso centrale durante i processi di sensitizzazione a lungo termine indotti da diversi farmaci d'abuso	152
Inhibition of tumor cell migration	152
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.	152
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system	151
Binding studies of dermorphin and its L-form on rat brain opioid receptors.	151
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	150
Pertussis toxin inhibits the antinociceptive action of morphine in the rat..	150
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.	149
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	149
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization	148
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.	148
Antitumor effects of cannabidiol , a nonpsychoative cannabinoid, on Human glioma cell lines	147
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.	147
Presence of a reduced opioid response in interleukin-6 knock out mice	146
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	145
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression.	145
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	144
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine..	143
Totale	18.963

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	106.489
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	106.489

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	941	0	0	0	0	0	0	0	0	0	168	295	478
2021/2022	1.930	192	203	182	251	58	89	71	94	94	282	149	265
2022/2023	2.722	265	165	192	326	157	582	10	378	399	75	120	53
2023/2024	4.570	717	743	725	832	902	350	31	76	100	28	23	43
2024/2025	2.706	39	42	483	78	74	174	100	211	349	217	222	717
2025/2026	5.444	424	379	137	792	581	433	1.386	369	702	241	0	0
Totale													29.750